SYLLABUS WIFI NETWORK: EVENTS2018 PASSWORD: EVENTS2018 - ICHP
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Illinois Council of Health-System Pharmacists 2018 Annual Meeting
September 13 - 15, 2018 | Oakbrook Terrace, Illinois
SYLLABUS
WiFi
Network: Events2018
Password: Events2018
e A p p !
Get th
https://attendify.com/app/icjejq/
• Up to the minute updates!
• Meeting materials and
presentation handouts at your
fingertips!
• Be prepared for session polls!
• Connect with other attendees!
ATE” YOUR
AND “ELEV
AD NOW CE!
DOWNLO EETING EXPERIEN
M
ICHPchat
Join us in our online community, ICHPchat! This
online community is exclusive to ICHP members
and allows members to connect with each other
in social forums by asking questions, sharing best
practices, attaching files, and more.
To get started, visit ICHPchat.org to create your
account and check out our Getting Started Guide.
CONTENTS 2018 ANNUAL MEETING PLANNING COMMITTEE
Maggie Allen
Kelsey Bridgeman
Abby Kahaleh
David Martin
Lida Thimothy
Trish Wegner
Tommy Chiampas Scott Meyers
Acknowledgements 3 Lara Ellinger Becky Ohrmund
Meeting-At-A-Glance 4 2018 ANNUAL MEETING VOLUNTEERS
Noelle Chapman Bernice Man David Tjhio
Christopher Crank David Martin Kristine VanKuiken
Meeting Sponsors 5 Travis Hunerdosse Radhika Polisetty Sarah Wieczorkiewicz
Milena McLaughlin Martina Powell
Conference Center Map 7
ICHP OFFICERS AND BOARD OF DIRECTORS
General Meeting ICHP EXECUTIVE OFFICERS ICHP REGIONAL DIRECTORS
Information 8 Travis Hunerdosse, President Amy Boblitt, Central
Charlene Hope, Immediate Past President Elise Wozniak, Northern
Noelle Chapman, President-elect Lynn Fromm, Southern
Accreditation Information 8 Kathryn Schultz, Treasurer
Jennifer Arnoldi, Secretary ICHP AFFILIATE PRESIDENTS
Scott Meyers, Executive Vice President Erika Hellenbart, Northern Illinois Society
Thursday 12 Ed Rainville, West Central Society
ICHP DIVISION DIRECTORS Jared Sheley, Metro East Society
Networking Session Mary Lee, Organizational Affairs Julie Downen, Sagamiss Society
Discussion Topics 16 Karin Terry, Professional Affairs
Lara Ellinger, Educational Affairs ICHP STUDENT CHAPTER
Carrie Vogler, Marketing Affairs PRESIDENTS
Friday 20 Christopher Crank, Government Affairs Erin Hermes, Chicago State
University College of Pharmacy
ICHP NETWORK AND Shivek Kashyap, Midwestern University
Town Hall Questions Chicago College of Pharmacy
& Discussion Topics 21 COMMITTEE CHAIRS Sara Koehnke, Roosevelt University
Bernice Man, New Practitioners Network
College of Pharmacy
Abby Kahaleh, Ambulatory Care Network
Brit Der, Rosalind Franklin University
Upcoming Events 27 David Tjhio, Committee on Technology
College of Pharmacy
Jennifer Phillips, KeePosted Committee,
James Reimer, Southern Illinois
Nominations Committee
University Edwardsville School of Pharmacy
Saturday 28 Henry Okoroike, University of Illinois
TECHNICIAN at Chicago College of Pharmacy
REPRESENTATIVE Hannah Dalogdog, University of
Pharmacy Action Fund 31 Clara Gary, Technician Representative Illinois at Chicago Rockford Campus
College of Pharmacy
Faculty and Disclosures 32
ICHP OFFICE STAFF
Scott Meyer, Melissa Dyrdahl
CPE Credit Instructions 36 Executive Vice President Communications Manager
Trish Wegner Jan Mark
Vice President of Professional Services Accountant
Pages for Notes 38
Maggie DiMarco Allen Jo Haley
Director of Operations and Customer Service Representative and
Continuing Education Administrator Pharmacy Tech Topics™ Specialist
Champion Sites 41
Heidi Sunday Jim Owen
Information Systems Manager Legislative Consultant
Polling Instructions 43
3
Images property of ©2018 Adobe Stock All information is accurate as of print date 8/30/18
ICHP 2018 ANNUAL MEETING
MEETING-AT-A-GLANCE
Taking Pharmacy to New Heights
September 13 - 15, 2018 | Oakbrook Terrace, Illinois
2018 ANNUAL MEETING GENERAL LEARNING OBJECTIVES
1. Recall evidence-based medicine practices related to various disease states.
2. State the impact of influenza and how pharmacists and technicians can affect
outcomes.
3. Describe the importance of a resilient pharmacy workforce.
4. Explain how technology can assist with and improve workflow.
5. Review ways to elevate skills in leadership and practice.
6. Discuss safe medication and quality improvement practices.
7. Recognize best practices in hospital and ambulatory care settings.
THURSDAY, SEPTEMBER 13, 2018 – Presented in partnership with the Pharmacy Learning Network.
TIME SESSION/EVENT ROOM
7:30am - 7:30pm ICHP Registration Desk Hours Foyer
7:30am - 8:30am Breakfast Venetian Room
8:30am - 12:00pm General Sessions Terrace Room
10:15am - 10:30am Break/Scavenger Hunt Foyer
12:00pm - 1:00pm Lunch Venetian Room
12:00pm - 1:00pm Past Presidents’ Lunch (invitation only) English Room
1:10pm - 2:55pm General Sessions Terrace Room
2:55pm - 3:10pm Afternoon Break/Scavenger Hunt Foyer
3:15pm - 4:15pm Exhibit Program Oak & Brook Rooms
4:15pm - 6:15pm General Sessions Terrace & Venetian Rooms
6:30pm - 7:30pm Networking Session & Reception Terrace & Venetian Rooms
FRIDAY, SEPTEMBER 14, 2018
TIME SESSION/EVENT ROOM
7:30am - 6:15pm ICHP Registration Desk Hours Foyer
7:30am - 8:00am Continental Breakfast Foyer
8:00am - 10:00am General Session Terrace & Venetian Rooms
8:00am - 10:00am Reverse Exhibit (invitation only) Crystal Room
10:00am - 12:00pm Exhibit Program and Break Oak & Brook Rooms
12:00pm - 1:00pm Lunch & Town Hall Meeting Terrace & Venetian Rooms
1:15pm - 2:40pm Keynote Session Terrace & Venetian Rooms
2:45pm - 6:00pm Track 1 - Pharmacy Practice Session English Room
2:45pm - 6:00pm Track 2 - Clinical Session Crystal Room
2:45pm - 6:00pm Track 3 - Management & Technology Session Terrace & Venetian Rooms
6:30pm - 9:30pm President’s Dinner (invitation only) Ditkas
SATURDAY, SEPTEMBER 15, 2018
TIME SESSION/EVENT ROOM
7:30am - 3:15pm ICHP Registration Desk Hours Foyer
7:30am - 8:00am Continental Breakfast Foyer
8:00am - 11:30am Track 1 - Ambulatory Care Session French Room
8:00am - 11:30am Track 2 - Pharmacy Practice Session Crystal Room
8:00am - 11:30am Track 3 - Student Session Venetian Room
11:30am - 1:00pm Lunch & Awards Program Terrace Room
1:00pm - 3:00pm Closing General Session Crystal Room
1:00pm - 3:00pm Residency Showcase Oak & Brook Rooms
WiFi AVAILABLE
THANK YOU Network:
Events2018
MEETING SPONSORS
Password:
Events2018
ICHP would like to thank these companies for providing sponsorships for the 2018 Annual Meeting.
GOLD SPONSORS
SILVER SPONSORS
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 5
DRURY LANE CONFERENCE WiFi
CENTER MAP Network:
Events2018
Password:
Events2018
Main Entrance ICHP Registration Desk Meeting Rooms
MAIN ENTRANCE
with a twist
registration
Auction
pac
FOYER FRENCH
BROOK OAK
ENGLISH
CRYSTAL VENETIAN TERRACE Exhibit Hall and
Residency Showcase
with us
socially!
/ichpnet /ichpnet /ichpnet
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 7
GENERAL MEETING INFO
REGISTRATION CONTINUING PHARMACY providers (11.75 contact hours
Meeting materials are available EDUCATION CREDIT from ICHP; 6.75 contact hours
for pick-up during designated Education sessions will be offered from NACCME for pharmacists.
hours at the meeting. CPE for CPE credit and registrants Available hours for technicians are
handouts will be available online may earn up to 18.5 contact 11.75 contact hours. - see detailed
prior to the meeting. The ICHP hours (1.85 CEUs) for pharmacists schedule.) Please refer to the
registration desk will be located and 11.75 contact hours (1.175 full meeting brochure (updated
in the conference center foyer. CEUs) for pharmacy technicians regularly) for complete accredited
Registration desk hours are: at this meeting (ICHP determines information. Note that CPE is
THURSDAY, SEPTEMBER 15 the number of contact hours for not available for technicians on
7:30 AM - 7:30 PM each session). Thursday.
FRIDAY, SEPTEMBER 16
Please note: PTCB requires CPhTs PROGRAM EVALUATIONS
7:30 AM - 6:15 PM
to earn only pharmacy technician- AND CREDIT
SATURDAY, SEPTEMBER 17 specific (‘T-specific’) credit to qualify ICHP ACCREDITED PROGRAMMING
7:30 AM - 3:15 PM for recertification. As of January In order to receive continuing
1, 2015, ALL CPE credit earned pharmacy education (CPE) credit,
MEETING DRESS CODE must be T-specific. In addition, the all meeting attendees will need to
The meeting dress code is number of allowable CPE hours access CESally.com to complete
business casual. The meeting earned through in-service training evaluations. Credit will be
room temperatures may vary is 5. reported to CPE Monitor.
– please remember to bring a
sweater or jacket. PROGRAMMING You will have 7 weeks after the
Annual Meeting to complete your
Program variations may occur.
NAME BADGES Syllabus includes all available
online evaluations and submit
Badges should be worn at all your request for CPE credit. Do
information at time of print.
times as a courtesy to other not delay in completing your
ICHP evaluations. Instructions
meeting participants. Your badge POLL EVERYWHERE
is your admission pass for all for completing ICHP live program
Session polls will be conducted evaluations online will be included
meeting sessions and exhibits,
using Poll Everywhere. Basic vi- in the meeting folder provided
and indicates any dietary
sual instructions can be found on to you at meeting registration.
restrictions.
page 43 of this syllabus. When completing your program
ARRANGEMENTS FOR evaluation for credit, if a CPE
SPECIAL ASSISTANCE ACCREDITATION program number ends in both ‘P’
The Illinois Council and ‘T’, pharmacists must choose
If you have any disability for
of Health-System the ‘P’ program and technicians
which you may require an
Pharmacists is must choose the ‘T’ program.
auxiliary aid or special service
while attending the meeting, accredited by the
please talk to the ICHP staff at Accreditation
the registration desk. Council for
Pharmacy Education as providers
TARGET AUDIENCE of continuing pharmacy education.
Registrants at the 2018 ICHP
Health-system pharmacists and
Annual Meeting may earn a
pharmacy technicians; pharmacy
maximum of 18.5 contact hours of
students.
continuing pharmacy education
in states that recognize ACPE
8 2018 ICHP ANNUAL MEETING
CPE MONITOR ACPE UNIVERSAL ACTIVITY NUMBERS - ICHP
Your NABP e-Profile ID is required 0121-0000-18-070-L06-P 0121-0000-18-079-L04-P
to receive CPE credit. Visit www. 0121-0000-18-070-L06-T 0121-0000-18-079-L04-T
mycpemonitor.net for more 0121-0000-18-071-L04-P 0121-0000-18-080-L03-P
information. 0121-0000-18-071-L04-T 0121-0000-18-080-L03-T
0121-0000-18-072-L07-P 0121-0000-18-081-L04-P
0121-0000-18-072-L07-T 0121-0000-18-081-L04-T
MEETING
0121-0000-18-073-L04-P 0121-0000-18-082-L01-P
PARTNERSHIP 0121-0000-18-073-L04-T 0121-0000-18-083-L04-P
Thursday’s programming 0121-0000-18-074-L04-P 0121-0000-18-084-L05-P
presented in partnership with the Pharmacy 0121-0000-18-074-L04-T 0121-0000-18-084-L05-T
Learning Network (PLN). 0121-0000-18-075-L05-P 0121-0000-18-085-L04-P
In support of improving 0121-0000-18-075-L05-T 0121-0000-18-085-L04-T
0121-0000-18-076-L01-P 0121-0000-18-086-L05-P
patient care, the 0121-0000-18-077-L01-P 0121-0000-18-086-L05-T
North American 0121-0000-18-078-L01-P
Center for Continuing
Medical Education
DOWNLOAD
(NACCME) is jointly accredited by the
Accreditation Council for Continuing
THE APP!
Medical Education (ACCME), the
Accreditation Council for Pharmacy
Education (ACPE), and the American
Nurses Credentialing Center (ANCC), to
provide continuing education for the CPE DEADLINE
healthcare team. End of the day
CPE MONDAY
This activity is approved for 6.75 October 29, 2018
contact hours (0.675 CEUs) of
continuing pharmacy education.
Partial credit is available for the Thursday
PLN programming, because NACCME is
a joint accredited provider of CME, CNE
and CPE.
UAN: JA0006201-0000-18-075-L01-P
This educational activity is
knowledge-based. Instructions for
NACCME accredited programs will be
provided.
For questions regarding PLN
S Y E AR!m
acivities, please call 609-371-1137.
THI ally.co
NEW
k-link
ES
to C credit!
PE
Quic rt your C
p o
to re
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 9
Visit us at Booth #200 Visit us at Booth #101
Networking Session
Thursday, September 13 6:30pm-7:30pm Terrace & Venetian Rooms
Academia ation Saf echnicia
ns
Medic
T
ulator macy P
ety
ct
Pra iti
ractice
Phar
Amb
yCare
oners
New
ip & Ma
adersh
na
gemen
Le
t
Why work with us?
Because you care.
We are a company dedicated to human lives and to ensure
that each individual receives the care and compassion
they deserve. UNITED Pharmacy Staffing prides itself in
supplying only the most qualified pharmacy personnel
available for interim & permanent placement.
REGISTERED CERTIFIED OPERATIONAL
PHARMACISTS PHARMACY MANAGERS
TECHNICIANS
CLINICAL DIRECTOR OF
SPECIALISTS EXPERIENCED PHARMACY
PROJECT
MANAGERS
Call toll free (866) 321-7747 or visit www.upstaffing.com
Booth #203THURSDAY, SEPTEMBER 13
7:30AM - 8:30AM 8:45AM - 9:30AM
Venetian Room Terrace Room
THURSDAY BREAKFAST VTE PREVENTION ACROSS THE
AT-A-GLANCE CONTINUUM: APPLICATIONS
Presented in partnership with the
Pharmacy Learning Network.
GENERAL SESSION OF CLINICAL EVIDENCE FOR
7:30AM - 7:30PM 8:30AM - 8:45AM EXTENDED PROPHYLAXIS
Terrace Room FROM INPATIENT TO
ICHP REGISTRATION DESK HOURS
Foyer INTRODUCTION OUTPATIENT CARE
At the end of this presentation,
7:30AM - 8:30AM pharmacist participants should be
BREAKFAST THURSDAY’S ACTIVITY IS able to:
Venetian Room
APPROVED FOR 6.75 CONTACT 1. Quantify the clinical and
economic burdens associated
8:30AM - 12:00PM HOURS (0.675 CEUs) OF
with VTE in patients admitted
GENERAL SESSIONS CONTINUING PHARMACY
for acute medical illness as
Terrace Room EDUCATION. well as post-discharge.
PARTIAL CREDIT IS AVAILABLE 2. Describe the standard of care
10:15AM - 10:30AM FOR THE THURSDAY PLN for VTE prophylaxis in the
BREAK/SCAVENGER HUNT
Foyer PROGRAMMING, BECAUSE acute hospitalization and post-
NACCME IS A JOINT discharge care settings.
3. Evaluate the latest clinical
12:00PM - 1:00PM ACCREDITED PROVIDER OF evidence associated with the
LUNCH CME, CNE AND CPE. use of DOACs for the acute and
Venetian Room UAN: JA0006201-0000-18-075-L01-P extended prophylaxis of VTE,
particularly the implications
12:00PM - 1:00PM of newly approved factor Xa
PAST PRESIDENTS’ LUNCH
inhibitors.
(invitation only)
4. Incorporate risk stratification
English Room
PLN CPE
nce: Health-System Pharmacists tools, patient-specific factors,
and shared decision-making
1:10PM - 2:55PM within the identification of
GENERAL SESSIONS Instructions for NACCME
accredited programs will be patients who would most
Terrace Room
benefit from extended VTE
provided.
prophylaxis.
2:55PM - 3:10PM 5. Lead the interdisciplinary
AFTERNOON BREAK / For questions regarding PLN
activities, please call care team in the management
SCAVENGER HUNT
of anticoagulant therapy for
Foyer 609-371-1137.
VTE prophylaxis, ensuring
individualized therapeutic
3:15PM - 4:15PM selection, patient-centric
EXHIBIT PROGRAM
education and monitoring, and
Oak & Brook Rooms
coordinated transitions of care
from hospital to outpatient
4:15PM - 6:15PM settings.
GENERAL SESSIONS
Type of Activity: Knowledge-based
Terrace & Venetian Rooms
0.75 contact hour (0.075 CEU)
UAN: JA0006201-0000-18-075-L01-P
6:30PM - 7:30PM Partial Credit available.
NETWORKING SESSION &
Mark A. Munger, PharmD, FCCP,
RECEPTION
FACC
Terrace & Venetian Rooms
12 2018 ICHP ANNUAL MEETINGWiFi AVAILABLE
Network:
Events2018
THURSDAY, SEPTEMBER 13 Password:
Events2018
9:30AM - 10:15AM 10:15AM - 10:30AM 11:15AM - 12:00PM
Terrace Room Foyer Terrace Room
ADDRESSING DIAGNOSTIC AND BREAK/SCAVENGER HUNT TACKLING THE COMPLEXITIES
THERAPEUTIC CHALLENGES IN OF BIOSIMILARS ACROSS
PULMONARY ARTERIAL PHARMACY SETTINGS
HYPERTENSION THROUGH 10:30AM - 11:15AM At the end of this presentation,
PHARMACIST INTERVENTION Terrace Room pharmacist participants should be
At the end of this presentation, OVERCOMING CHALLENGES IN able to:
THE MANAGEMENT OF 1. Outline the requirements
pharmacist participants should be
for biosimilars approval
able to: INVASIVE FUNGAL INFECTIONS such as the clinical data
1. Recognize the barriers to a At the end of this presentation, package, totality of evidence,
timely PAH diagnosis and the pharmacist participants should be extrapolation of data,
clinical and socioeconomic able to: interchangeability, and
impact of diagnostic delays. 1. Describe the current substitution.
2. Outline the diversity of PAH challenges associated with the 2. Evaluate the clinical data
pathophysiologic mechanisms, management of IFI. supporting the safety,
therapeutic targets, and 2. Compare clinical data of efficacy, biosimilarity, and
patient types with respect to available antifungal therapies, interchangeability of approved
impact on clinical outcomes including differences in and late-stage biosimilars
and therapeutic design. the spectrum of activity, 3. Describe the impact of current
3. Evaluate traditional and mechanisms-of-action, PK and and emerging regulatory
newer approaches to the PD, tissue penetration, and and legal requirements on
management of PAH with adverse effects. biosimilar interchangeability
respect to their mechanisms 3. Implement timely and designation, switching/
of action, efficacy, safety, informed clinical decisions comparability studies,
indications, and appropriate that incorporate the latest pharmacovigilance, product
use across patient populations. evidence with respect tracking, and accessibility.
4. Employ pharmacy practice to prophylactic, empiric, 4. Integrate new and emerging
strategies to optimize the preemptive, and targeted biosimilars into clinical
long-term management antifungal treatment. care plans, systems-based
of PAH through informed, 4. Lead the healthcare team processes, formulary
individualized, and in ensuring appropriate IFI discussions, and provider/
coordinated care. treatment monitoring and patient communication
Type of Activity: Knowledge-based modification, medication strategies.
0.75 contact hour (0.075 CEU) reconciliation, and prevention Type of Activity: Knowledge-based
UAN: JA0006201-0000-18-075-L01-P of drug toxicities and 0.75 contact hour (0.075 CEU)
Partial Credit available. interactions. UAN: JA0006201-0000-18-075-L01-P
Douglas Jennings, PharmD, FCCP, Type of Activity: Knowledge-based Partial Credit available.
FAHA, FACC, BCPS 0.75 contact hour (0.075 CEU) Steven Lucio, PharmD, BCPS
UAN: JA0006201-0000-18-075-L01-P
Partial Credit available.
James S. Lewis II, PharmD, FIDSA 12:00PM - 1:00PM
Venetian Room
LUNCH
12:00PM-1:00PM
English Room
PAST PRESIDENTS’ LUNCH
(Invitation Only)
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 13THURSDAY, SEPTEMBER 13
GENERAL SESSION 1:55PM - 2:55PM 2:55PM - 3:10PM
1:10PM - 1:55PM Terrace Room Venetian Room
Terrace Room COMMON MEDICATION AFTERNOON BREAK /
EXAMINING THE ERRORS WITH ORAL SCAVENGER HUNT
PHARMACOLOGIC PROFILES ANTICOAGULANTS
AND APPROPRIATE At the end of this presentation,
INTEGRATION OF TREATMENT pharmacist participants should be 3:15PM - 4:15PM
ADVANCES IN AML able to: Oak & Brook Rooms
1. Describe errors and
At the end of this presentation,
potentially hazardous EXHIBIT PROGRAM
pharmacist participants should be
able to: situations associated with oral
1. Describe the factors that anticoagulants.
contribute to poor clinical 2. Evaluate the current trends
outcomes and the economic in errors with the use of the
burden of AML. newer oral anticoagulants.
2. Identify the challenges with 3. Outline strategies for
the current standard of preventing anticoagulation
AML care and traditional errors using technology and
therapeutic options in terms other system changes.
of the initiation, tolerability, 4. Describe metrics that could be
and toxicity of treatment; and used to measure the level of
impact on patient survival, patient harm with the use of
hospitalizations, and quality oral anticoagulants.
of life. Type of Activity: Knowledge-based
3. Assess the role of novel 1.0 contact hour (0.1 CEU)
chemotherapeutic UAN: JA0006201-0000-18-075-L01-P
formulations and targeted Partial Credit available.
agents in the treatment of Matthew Grissinger, RPh, FISMP,
AML in terms of clinical FASCP
outcomes, pharmacologic
profiles, reduced toxicity, and
pharmacoeconomic data.
4. Integrate new
chemotherapeutic
formulations and targeted
agents into AML care and
pharmacy medication
management plans.
Type of Activity: Knowledge-based
0.75 contact hour (0.075 CEU)
UAN: JA0006201-0000-18-075-L01-P
Partial Credit available.
Christopher A. Fausel PharmD,
BCPS, BCOP
14 2018 ICHP ANNUAL MEETINGWiFi AVAILABLE
Network:
Events2018
THURSDAY, SEPTEMBER 13 Password:
Events2018
GENERAL SESSION 5:00PM - 5:45PM 5:45PM - 6:15PM
4:15PM - 5:00PM Terrace & Venetian Rooms Terrace & Venetian Rooms
Terrace & Venetian Rooms THERAPEUTIC ADVANCES MEET THE EXPERTS: PANEL
RECOGNIZING AND MANAGING IN HYPERKALEMIA: DISCUSSION WITH PLN
VOD IN AFFECTED AND AT-RISK A PHARMACIST’S GUIDE TO FACULTY
PATIENTS PATIENT IDENTIFICATION AND At the end of this presentation,
At the end of this presentation, TREATMENT pharmacist participants should be
pharmacist participants should be able to:
able to: At the end of this presentation,
1. Discuss current evidence-
1. Outline the risk factors and pharmacist participants should be
based recommendations of
diagnostic criteria associated able to:
the discussed disease states
with VOD for the timely 1. Outline the clinical and
towards improving patient
identification of at-risk and socioeconomic consequences of
outcomes.
affected patients. unrecognized and undertreated
2. Utilize contemporary medical
2. Distinguish among traditional chronic hyperkalemia.
guidelines and strategies in
and newer approaches to VOD 2. Identify the risk factors and
the wide variety of medical
management with respect pathophysiologic mechanisms
disorders presented.
to their clinical rationale associated with the
3. Explore new roles for health-
for use, efficacy, safety, and development of hyperkalemia
system pharmacists in our ever
tolerability. in key patient populations.
expanding profession, as it
3. Evaluate the available evidence 3. Evaluate the latest clinical
relates to direct patient care.
surrounding the clinical data and surrounding new
Type of Activity: Knowledge-based
and cost benefits of early or and emerging potassium
0.5 contact hour (0.05 CEU)
preventative VOD treatment in binding agents with respect
UAN: JA0006201-0000-18-075-L01-P
key patient populations. to mechanisms of action,
Partial Credit available.
4. Integrate the latest clinical efficacy, safety, indication,
Randolph V. Fugit, PharmD, BCPS
evidence and expert and therapeutic placement in
Darren W. Grabe, PharmD
recommendations into hyperkalemia management
Steven Lucio, PharmD, BCPS
strategies to overcome barriers strategies.
Mark A Munger, PharmD, FCCP,
to optimal VOD diagnostic and 4. Advance the long-term
management of hyperkalemia FACC
therapeutic practices.
Type of Activity: Knowledge-based in pharmacy practice through
0.75 contact hour (0.075 CEU) measures that facilitate at-risk
UAN: JA0006201-0000-18-075-L01-P patient monitoring, promote
Partial Credit available. patient/provider education,
Christopher A. Fausel, PharmD, and integrate newer therapies
BCPS, BCOP for optimal patient outcomes.
Type of Activity: Knowledge-based
0.75 contact hour (0.075 CEU)
UAN: JA0006201-0000-18-075-L01-P
Partial Credit available.
Darren W. Grabe, PharmD
DOWNLOAD
THE APP!
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 15THURSDAY, SEPTEMBER 13
6:30PM - 7:30PM NETWORKING SESSION DISCUSSION TOPICS
Terrace & Venetian Rooms ACADEMIA
NETWORKING SESSION AND 1. What are questions to ask or items to consider when interviewing for a
job in academia?
RECEPTION 2. What is the importance of pursuing faculty promotion?
3. How should colleges develop and mentor faculty?
4. What are some tips for precepting the difficult student or resident?
ACADEMIA
Jan Engle, PharmD, FAPhA
AMBULATORY CARE
1. What role do you have in reducing medication errors?
AMBULATORY CARE 2. What novel transitions of care pharmacy-led services have you been a
Brooke L. Griffin, PharmD, BCACP part of?
3. What innovative medication management services do you have?
4. What are the challenges you are facing in your current ambulatory care
LEADERSHIP/MANAGEMENT roles?
Anthony Scott, PharmD 5. How can ICHP help you maintain/expand your current service?
6. What type of ambulatory care programming would you like to see ICHP
facilitate/coordinate?
MEDICATION SAFETY
Ann Jankiewicz, PharmD, BCPS,
LEADERSHIP/MANAGEMENT
FASHP 1. What strategies have you used for empowering pharmacists and
technicians?
NEW PRACTITIONERS 2. What have you implemented in your institution to create high-performing
interprofessional teams?
Bernice Man, PharmD
3. What major issues have you had to address in anticipation of regulatory
inspections?
PHARMACY PRACTICE 4. What can leaders do to get technicians involved in ICHP?
Ed Rainville, PharmMS
MEDICATION SAFETY
TECHNICIANS 1. Do you have issues with safe labeling practices?
Martina Powell, CPhT 2. EMR transitions – issues and lessons learned
3. How do you use your smart pump data? Is there a dedicated team that
reviews and analyzes it consistently?
4. What LASA errors have you had and what strategies have you
implemented to prevent recurrence?
NEW PRACTITIONERS
1. How have you transitioned from being a student or resident into your first full-time position?
2. What are your 5-year career goals and how do you plan to attain those goals? Do you have aspirations to join the
management team in the future?
3. What marketing strategies can ICHP utilize to engage more New Practitioner members and encourage them to join
or maintain ICHP membership?
4. Do you know the differences between mentors and sponsors? Do you
have either or both?
PHARMACY PRACTICE
1. How have you cleaned your cleanroom?
2. Where are you with and compliance?
3. Are you doing anything exciting with shortages?
4. What is your institution doing to combat the opioid crisis?
5. What are you doing about medical marijuana?
PHARMACY TECHNICIANS
1. What are the pros and cons of technician certifications?
2. What does ICHP need to do to get more technician involvement?
3. How can technicians effectively work with new grads?
16 2018 ICHP ANNUAL MEETINGOCTAPHARMA IS PROUD TO SUPPORT
The Illinois Council of Health-System Pharmacists
and joins them in celebrating the 2018 Annual Meeting
Octapharma is one of the largest human plasma
protein products manufacturers in the world and
has been committed to patient care and medical
innovation since 1983. Our core focus is the
development and production of proteins from
human plasma and human cell lines. Octapharma
employs more than 7,600 people worldwide to
support the treatment of patients in 113 countries
with coagulation disorders, immune disorders,
and other critical illnesses.
Visit us online at
www.octapharmausa.com
©2018 Octapharma USA, Inc. All rights reserved.
Date of preparation, 8/2018. OCTA-0217-PAD
Booth #104
FIND ALL OF OUR
EXHIBITORS &
SPONSORS ON
THE INTERACTIVE
EXHIBITOR MAP!
Get it on the App!
TOUCH A BOOTH TO SEE
THE EXHIBITOR INFO!Booth #301 Visit us at Booth #212
Visit us at Booth #400 Visit us at Booth #213
WIFI AVAILABLE
Network: Events2018
FRIDAY, SEPTEMBER 14 Password: Events2018
7:30AM - 8:00AM 8:00AM - 10:00AM
Foyer
FRIDAY CONTINENTAL BREAKFAST
Crystal Room
AT-A-GLANCE REVERSE EXHIBIT
(invitation only)
7:30AM - 6:15PM GENERAL SESSION
ICHP REGISTRATION DESK HOURS
8:00AM - 10:00AM
Terrace & Venetian Rooms 10:00AM - 12:00PM
Foyer
THE FLU STOPS HERE: Oak & Brook Rooms
7:30AM - 8:00AM ENABLING PHARMACISTS AND EXHIBIT PROGRAM & BREAK
CONTINENTAL BREAKFAST PHARMACY TECHNICIANS TO
Foyer
JOIN THE FIGHT
12:00PM - 1:00PM
8:00AM - 10:00AM At the end of this presentation,
Terrace & Venetian Rooms
GENERAL SESSION pharmacist participants should be
Terrace & Venetian Rooms able to: LUNCH & TOWN HALL MEETING
1. Assess data about the impact
8:00AM - 10:00AM of influenza illness and vaccine
REVERSE EXHIBIT effectiveness.
(invitation only) 2. Evaluate evidence regarding
Crystal Room strategies to optimize
vaccination rates for patients
10:00AM - 12:00PM and health care workers.
EXHIBIT PROGRAM & BREAK 3. Propose factors to consider in
Oak & Brook Rooms product selection of influenza
vaccine.
12:00PM - 1:00PM 4. Apply knowledge regarding
LUNCH & TOWN HALL MEETING influenza vaccine and antiviral
Terrace & Venetian Rooms therapies to clinical scenarios.
At the end of this presentation,
1:15PM - 2:40PM technician participants should be
KEYNOTE SESSION able to:
Terrace & Venetian Rooms 1. Evaluate information
POLLS:
regarding the impact of
2:45PM - 6:00PM influenza and influenza
PollEv.com/ichp OR
TRACK 1 – PHARMACY vaccine on patient outcomes.
PRACTICE SESSION 2. Design strategies to improve
PollEv.com/ichp3 OR
English Room knowledge and awareness
regarding influenza and the
2:45PM - 6:00PM
TRACK 2 – CLINICAL SESSION
vaccine.
3. Propose pharmacy-based PollEv.com/ichp5
Crystal Room activities to optimize influenza Varies by Room
vaccination rates.
2:45PM - 6:00PM Type of Activity: Application- Instructions on page 43
TRACK 3 – MANAGEMENT & based
TECHNOLOGY SESSION 2.0 contact hours (0.2 CEUs)
Terrace & Venetian Rooms UANs: 0121-0000-18-070-L06-P
0121-0000-18-070-L06-T
6:30PM - 9:30PM No partial credit available.
PRESIDENT’S DINNER Michael D. Hogue, PharmD, FAPhA
(invitation only) Dennis Williams, PharmD, BCPS, AE-C
Ditka’s
This activity is supported by an educational grant from
Sanofi Pasteur U.S. This activity will be recorded and
used for continuing pharmacy education home study.
20 2018 ICHP ANNUAL MEETINGParticipate in the discussion
FRIDAY, SEPTEMBER 14 by using our
Poll Everywhere links!
TOWN HALL QUESTIONS & DISCUSSION TOPICS
1. The opioid crisis continues to take center stage for healthcare in Illinois and it does not appear to be getting
much better. In fact in many communities it has gotten worse. In addition, DEA efforts to decrease the supply
of opioids is causing problems for hospitals and other healthcare facilities across the nation. What can ICHP do
to combat this crisis? What type of programming or services would be of value and feasible for ICHP to develop
alone or in collaboration with Illinois Colleges of Pharmacy, IPhA, IRMA or other local, State and national entities
that would help frontline practitioners, first responders and community leaders?
2. In 2017 the Illinois General Assembly created the Collaborative Pharmaceutical Task Force to review 16 different
concerns with today’s pharmacy practice in addition to reviewing the entire Illinois Pharmacy Practice Act
for the purpose of updating it. ICHP is represented on Collaborative Pharmaceutical Task Force by Scott
Meyers. The Task Force has met 9 times to date and has begun developing recommendation to be presented
to the General Assembly in 2019. Are there any specific changes you would like to see made to the Practice Act
regarding workload issues, e-prescribing or any other section of the Practice Act?
3. ICHP is redesigning how it provides news and information to you this fall. The KeePosted, ICHP’s newsjournal
will now be a quarterly publication (print and electronic) delivered to all members in February, May, August
and November. In addition, newsworthy information will be delivered digitally (e-mail, Facebook®, LinkedIn®
and Twitter®) as it occurs, including legislative and regulatory updates, Board of Pharmacy News, educational
offerings, job postings and affiliate chapter news. It is critical that ICHP have an e-mail address for each member
that will receive e-mail updates without being blocked by spam filters and firewalls. Are there any questions?
4. The ICHP Division of Educational Affairs is considering a redesign of our Annual Meeting. The current three-day
format in Oakbrook Terrace is being reviewed and the Division would like members to consider the desirability
of a shorter meeting located in downtown Chicago as an option. The Division will include an array of meeting
format and location questions in its 2019 Educational Needs Assessment but since we have many of you long-
time Annual Meeting attendees present would any of you like to share your thoughts on any desired changes?
5. The ICHP Champions Program: 1) How many of you know what it is? 2) How many have a Champion at your
institution? 3) How many of you are your institution’s Champion? 4) If you don’t participate is it because it’s not
worth the effort? 5) If you do participate what challenges/obstacles are there at your workplace?
6. How many of you know what ICHP’s “Double Dose” is? The Double Dose is a member recruitment offer in
which a current member may recruit a non-member colleague of the same membership category (pharmacist
for pharmacist or pharmacy technician for pharmacy technician) to join ICHP when the member renews their
own membership dues for the price of one membership. In other words, $125 will provide membership for a
renewing pharmacist member of ICHP and a non-member colleagues for one year. Former ICHP members are
eligible if they have not been a member of ICHP for at least 12 months. How many of you use or have used this
offer?
7. Do you (ICHP members) use the Toolkits available on the ICHP Website www.ichpnet.org and if so, for which
situations?
8. What would you like to see ICHP do to promote provider status?
9. In working for “Provider Status” in Illinois, should ICHP push for a new level of pharmacist, such as an Advanced
Practice Pharmacist or Pharmacist Clinician or should every pharmacist who passes the NAPLEX and MPJE be
allowed to be a Provider?
10. In a perfect world where ICHP had ample resources, what would you like to see it provide? Besides lower or no dues!
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 21WIFI AVAILABLE
Network: Events2018
FRIDAY, SEPTEMBER 14 Password: Events2018
KEYNOTE SESSION TRACK 1 –PHARMACY 3:30PM - 4:00PM
1:15PM - 2:40PM PRACTICE SESSION English Room
Terrace & Venetian Rooms 2:45PM - 3:30PM
PROS AND CONS OF RFID
JOURNEY TO A RESILIENT AND English Room
TECHNOLOGY
THRIVING PHARMACY NEW COMPOUNDING
At the end of this presentation,
WORKFORCE REGULATIONS pharmacist participants should be
At the end of this presentation, At the end of this presentation, able to:
pharmacist participants should be pharmacist participants should be 1. Explain the benefits and challenges
able to: able to: of using RFID technology when
1. Explain why clinician 1. Describe three sources of filling OR trays.
burnout is a patient care and contaminants to compounded 2. List other areas within the
healthcare workforce problem sterile preparations. pharmacy that can benefit from
that needs addressing. 2. Identify organizations that RFID technology.
2. Discuss what is known about have enforcement authority At the end of this presentation,
burnout in the pharmacy with respect to USP . technician participants should be able
workforce. 3. List three proposed changes to:
3. Describe the National to USP : separation of 1. Explain the benefits and challenges
Academy of Medicine Clinician Hazardous Drug standards, of using RFID technology when
Well-Being and Resilience new product categories, new filling OR trays.
Action Collaborative. beyond use date. 2. List other areas within the
4. Identify strategies to impact 4. Identify important remaining pharmacy that can benefit from
well-being and resilience dates in the USP RFID technology.
in pharmacists, pharmacy timeline to enforcement. Type of Activity: Knowledge-based
residents, student pharmacists At the end of this presentation, 0.5 contact hour (0.05 CEU)
and pharmacy technicians. technician participants should be UANs: 0121-0000-18-073-L04-P
At the end of this presentation, able to: 0121-0000-18-073-L04-T
technician participants should be 1. Describe three sources of No partial credit available.
able to: contaminants to compounded Cristina Aguilar, CPhT
1. Explain why clinician sterile preparations.
burnout is a patient care and 2. Identify organizations that
healthcare workforce problem have enforcement authority 4:00PM - 4:15PM
that needs addressing. with respect to USP . Foyer
2. Discuss what is known about 3. List three proposed changes BREAK
burnout in the pharmacy to USP : separation of
workforce. Hazardous Drug standards,
3. Describe the National new product categories, new
Academy of Medicine Clinician beyond use date.
Well-Being and Resilience 4. Identify important remaining
Action Collaborative. dates in the USP
4. Identify strategies to impact timeline to enforcement.
well-being and resilience Type of Activity: Knowledge-based
in pharmacists, pharmacy 0.75 contact hour (0.075 CEU)
residents, student pharmacists UANs: 0121-0000-18-072-L07-P
and pharmacy technicians. 0121-0000-18-072-L07-T
Type of Activity: Knowledge-based No partial credit available.
1.5 contact hours (0.15 CEUs)
UANs: 0121-0000-18-071-L04-P
Janet Mary Hinkes, PharmD, POLLS:
MBA
0121-0000-18-071-L04-T PollEv.com/ichp
No partial credit available.
Anna Legreid Dopp, PharmD OR PollEv.com/ichp3
OR PollEv.com/ichp5
Varies by Room
Instructions on page 43
22 2018 ICHP ANNUAL MEETINGFRIDAY, SEPTEMBER 14
ABOUT OUR KEYNOTE SPEAKER:
Anna Legreid Dopp attended North Dakota State University for pre-
pharmacy coursework and completed a Doctor of Pharmacy degree in 2002
from the University of Minnesota College of Pharmacy in Minneapolis,
Minnesota. Upon graduation she worked at Medtronic, Inc. in the Cardiac
Rhythm Disease Management Clinical and Outcomes Research department.
In May 2005 she accepted a position as a Clinical Assistant Professor at the
University of Wisconsin School of Pharmacy in Madison, Wisconsin. In 2008,
she took a leave of absence from that role to complete a Congressional
Health Care Policy Fellow Program in Washington, DC where she worked
on health and social policy in the office of Senator Joe Lieberman. Subsequent to the fellowship,
she served in roles at the University of Wisconsin Hospital and Clinics as a medication use policy
analyst and the Pharmacy Society of Wisconsin as the Vice President of Public Affairs and editor
of the Journal of the Pharmacy Society of Wisconsin. In 2016, Anna joined the American Society of
Health-System Pharmacists (ASHP) in Bethesda, Maryland as the Director of Clinical Guidelines and
Quality Improvement. Her role with ASHP includes developing therapeutic guidance documents and
collaborating with the National Quality Forum, The Joint Commission, and the Pharmacy Quality
Alliance regarding quality improvement initiatives.
DOWNLOAD
CPE DEADLINE
THE APP! End of the day
MONDAY
October 29, 2018
NEW !
H I S Y E AR
T link to
Quick- y.com
CESall rt your
to repo redit!
CPE c
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 23WIFI AVAILABLE
Network: Events2018
FRIDAY, SEPTEMBER 14 Password: Events2018
4:15PM - 5:15PM 5:15PM - 6:00PM TRACK 2 – CLINICAL SESSION
English Room English Room 2:45PM - 4:00PM
LEADERSHIP GEMS ISMP BEST PRACTICES FOR Crystal Room
• ADVANCED ROLES 2018/2019 CLINICAL PEARLS 2018
• RX TECH CARES At the end of this presentation, • DIRECTIONS TO
At the end of this presentation, pharmacist participants should be DEPRESCRIBING IN
pharmacist participants should be able to: OLDER ADULTS
able to: 1. List the Institute for Safe
1. Explain why advanced • PHARMACOGENICS: AN
Medication Practices (ISMP) INPATIENT PERSPECTIVE
pharmacy technician roles are
2018-2019 Targeted Medication • UPDATES ON CLOSTRIDIUM
needed in pharmacy.
2. Describe the training involved Safety Best Practices. DIFFICILE
with advanced pharmacy 2. Review strategies for
At the end of this presentation,
technician roles. compliance with the ISMP
pharmacist participants should be
3. Recognize that Pharmacy recommendations.
able to:
Technicians are 3. Identify barriers to achieving
paraprofessionals. 1. Discuss risks of polypharmacy
compliance with the ISMP
4. Explain what RX Techs CARES in older adults and approaches
recommendations.
means. to de-prescribe in this
At the end of this presentation,
At the end of this presentation, population.
technician participants should be
technician participants should be 2. Review updated tools to assist
able to:
able to: with safe prescribing in older
1. Explain why advanced 1. List the Institute for Safe
adults.
pharmacy technician roles are Medication Practices (ISMP)
3. Describe considerations for
needed in pharmacy. 2018-2019 Targeted Medication
implementing and applying
2. Describe the training involved Safety Best Practices.
pharmacogenomic testing in
with advanced pharmacy 2. Review strategies for
technician roles. the inpatient setting.
compliance with the ISMP
3. Recognize that Pharmacy 4. State Clostridium difficile
recommendations.
Technicians are infection treatment
3. Identify barriers to achieving
paraprofessionals. recommendations consistent
compliance with the ISMP
4. Explain what RX Techs CARES with the 2018 IDSA guidelines
recommendations.
means. based on patient-specific
Type of Activity: Knowledge-based Type of Activity: Knowledge-based
factors.
1.0 contact hour (0.1 CEU) 0.75 contact hour (0.075 CEU)
5. Recall treatment
UANs: 0121-0000-18-074-L04-P UANs: 0121-0000-18-075-L05-P
considerations for reducing
0121-0000-18-074-L04-T 0121-0000-18-075-L05-T
the risk of Clostridium difficile
No partial credit available. No partial credit available.
Clara Gary, CPhT recurrence.
Ann Jankiewicz, PharmD, BCPS,
Type of Activity: Knowledge-based
Brittany Huff, PharmD FASHP
1.25 contact hours (0.125 CEUs)
UAN: 0121-0000-18-076-L01-P
No partial credit available.
Kevin Bacigalupo, PharmD, BCPS,
BCGP
James C. Lee, PharmD, BCACP
Nick Van Hise, PharmD, BCPS
24 2018 ICHP ANNUAL MEETINGFRIDAY, SEPTEMBER 14
4:15PM - 5:15PM 5:15PM - 6:00PM TRACK 3 – MANAGEMENT/
Crystal Room Crystal Room TECHNOLOGY SESSION
UPDATES IN DIABETES AND DO WE HAVE THIS? A 2:45PM - 4:00PM
CARDIOVASCULAR NEONATAL AND PEDIATRIC Terrace & Venetian Rooms
TECHNOLOGY PEARLS 2018
DISEASE MANAGEMENT: ARE EMERGENCY TOOLKIT
• OPIOID DASHBOARD
YOU MAKING THE LINK? At the end of this presentation, • IV ROOM WORKFLOW SYSTEM -
At the end of this presentation, pharmacist participants should be
PROS AND CONS
pharmacist participants should be able to:
• A DUAL SYSTEM SOLUTION TO
able to: 1. Summarize the antibiotics
recommended for neonatal INVENTORY OPTIMIZATION
1. Apply recent changes to blood
sepsis and the importance • USING FORMS AND
pressure goals in patients with
of having them available for SPREADSHEETS TO EXPEDITE
diabetes.
2. Assess the role of new urgent administration once a REQUESTS AND COLLECT
antihyperglycemic therapies patient is identified. DOCUMENTATION
in preventing major adverse 2. Describe the pathophysiology At the end of this presentation,
cardiovascular events. of ductal dependent congenital pharmacist participants should be
3. Discuss the benefits, heart disease and the need for able to:
concerns, and barriers immediate administration of 1. Describe the difference
when incorporating new alprostadil. between a discrepancy and
cardiovascular risk strategies 3. Discuss the recommendations an exception as related
in patients with diabetes. for zidovudine therapy in to controlled substance
Type of Activity: Application- neonates born with maternal inventory management.
based HIV exposure. 2. List three examples of
1.0 contact hour (0.1 CEU) Type of Activity: Knowledge-based measures which can help
UAN: 0121-0000-18-077-L01-P 0.75 contact hour (0.075 CEU) detect and minimize drug
No partial credit available. UAN: 0121-0000-18-078-L01-P diversion and how to generate
Denise Kolanczyk, PharmD, No partial credit available. reports and analytics to assess
BCPS-AQ Cardiology Margaret Heger, PharmD, BCPPS the measures.
Jennifer D’Souza, PharmD, CDE, 3. Describe the pros and cons
BC-ADM on using IV room workflow
Erika Hellenbart, PharmD, BCPS software.
4. Describe the process of
concurrently implementing
a new carousel inventory
management system, along
with an automated unit dose
packaging system in a new
hospital inpatient pharmacy.
POLLS: 5. Discuss the cost savings
associated with the
PollEv.com/ichp OR implementation of this project.
6. Explain how forms can be set
PollEv.com/ichp3 OR up to expedite requests or
collect documentation.
PollEv.com/ichp5 At the end of this presentation,
technician participants should be
Varies by Room able to:
1. Describe the difference
Instructions on page 43 between a discrepancy and
an exception as related
to controlled substance
inventory management.
2. List three examples of
measures which can help
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 25WIFI AVAILABLE
Network: Events2018
FRIDAY, SEPTEMBER 14 Password: Events2018
detect and minimize drug 4:15PM - 5:15PM 5:15PM - 6:00PM
diversion and how to generate Terrace & Venetian Rooms Terrace & Venetian Rooms
reports and analytics to assess HOUSE OF CARDS: THE IN AND REVOLUTIONIZING THE
the measures. OUT OF THE PATIENT PHARMACY SUPPLY CHAIN
3. Describe the pros and cons PROTECTION AND At the end of this presentation,
on using IV room workflow AFFORDABLE CARE ACT pharmacist participants should be
software.
At the end of this presentation, able to:
4. Describe the process of
pharmacist participants should be 1. State services provided by an
concurrently implementing
able to: integrated service center.
a new carousel inventory
1. Outline key provisions of 2. Describe potential cost savings
management system, along
the Patient Protection and from streamlining inventory.
with an automated unit dose
Affordable Care Act (PPACA). 3. Explain how technology
packaging system in a new
2. Explain support and criticism can be leveraged to manage
hospital inpatient pharmacy.
of PPACA. inventory.
5. Discuss the cost savings
3. Explain efforts to date of the At the end of this presentation,
associated with the
Congress to repeal, replace, technician participants should be
implementation of this project.
and reform the PPACA and able to:
6. Explain how forms can be set
describe current efforts to 1. State services provided by an
up to expedite requests or
revise the law. integrated service center.
collect documentation.
At the end of this presentation, 2. Describe potential cost savings
Type of Activity: Knowledge-based
technician participants should be from streamlining inventory.
1.25 contact hours (0.125 CEUs)
able to: 3. Explain how technology
UANs: 0121-0000-18-079-L04-P
1. Outline key provisions of can be leveraged to manage
0121-0000-18-079-L04-T
the Patient Protection and inventory.
No partial credit available.
Affordable Care Act (PPACA). Type of Activity: Knowledge-based
Katherine Gauen, PharmD
2. Explain support and criticism 0.75 contact hour (0.075 CEU)
Josh Schmees, PharmD
of PPACA. UANs: 0121-0000-18-081-L04-P
Sarah Seward, PharmD, BCPS
3. Explain efforts to date of the 0121-0000-18-081-L04-T
Reina Shimozono, PharmD
Congress to repeal, replace, No partial credit available.
and reform the PPACA and Trac Pham, RPh, MS, MBA
describe current efforts to
4:00PM - 4:15PM revise the law.
Foyer Type of Activity: Knowledge-based 6:30PM - 9:30PM
1.0 contact hour (0.1 CEU)
BREAK UANs: 0121-0000-18-080-L03-P
Ditka’s
0121-0000-18-080-L03-T PRESIDENT’S DINNER
No partial credit available. (invitation only)
Joelle Farano, PharmD
CPE DEADLINE
End of the day
POLLS:
MONDAY
October 29, 2018 PollEv.com/ichp OR
PollEv.com/ichp3 OR
PollEv.com/ichp5
Varies by Room
Instructions on page 43
26 2018 ICHP ANNUAL MEETINGThursday, September 13
through 11:00AM on
Saturday, September 15
Upcoming Events
2018 - 2019
American Heart Association ICHP Leadership Retreat ICHP Spring Meeting
Heart Walk (invitation only) March 28-30, 2019
September 22, 2018 October 26-27, 2018 Collinsville, IL
Oak Brook, IL Zion, IL
ICHP Annual Meeting
American Heart Association ICHP Legislative Day September 12-14, 2019
Heart Walk To be determined Oakbrook Terrace, IL
October 6, 2018 Springfield, IL
Carterville, IL
ichpnet.org/eventsSATURDAY, SEPTEMBER 15
7:30AM - 8:00AM 9:15AM - 9:30AM
Foyer Foyer
SATURDAY CONTINENTAL BREAKFAST BREAK
AT-A-GLANCE
7:30AM - 3:15PM TRACK 1 – AMBULATORY CARE 9:30AM - 11:30AM
ICHP REGISTRATION DESK HOURS
SESSION French Room
8:00AM - 9:15AM A CALL TO ACTION:
Foyer French Room AMBULATORY CARE IN ILLINOIS
PHARMACIST CONTRACEPTIVE
7:30AM - 8:00AM PRESCRIBING: A THERAPEUTIC
At the end of this presentation,
CONTINENTAL BREAKFAST pharmacist participants should be
REVIEW AND ILLINOIS STATUS able to:
Foyer UPDATE 1. Examine the gap in defining
8:00AM - 11:30AM At the end of this presentation, clear roles for pharmacists
TRACK 1 – AMBULATORY CARE pharmacist participants should be providing patient care in
SESSION able to: ambulatory care settings in
French Room 1. Compare available Illinois.
hormonal contraceptive 2. Interpret, from a national
8:00AM - 11:30AM products, patient eligibility, perspective, current
TRACK 2 – PHARMACY and resources needed to healthcare challenges and
PRACTICE SESSION incorporate contraceptive sustainable opportunities for
Crystal Room prescribing into practice. pharmacists in ambulatory
2. Given a patient case, utilize care settings.
8:00AM - 11:30AM the MEC, the Pharmacist’s 3. Evaluate the impact of
TRACK 3 – STUDENT SESSION Patient Care Process, and ambulatory care clinical
Venetian Room other available resources pharmacists on clinical and
to create and implement economic outcomes in value-
11:30AM - 1:00PM a comprehensive patient based payment models.
LUNCH & AWARDS PROGRAM contraceptive plan. Type of Activity: Application-
Terrace Room 3. Discuss current and pending based
legislation in Illinois and 2.0 contact hours (0.2 CEUs)
1:00PM - 3:00PM other states and review UAN: 0121-0000-18-083-L04-P
CLOSING GENERAL SESSION experiences of pharmacist No partial credit available.
Crystal Room contraceptive prescribing Brian Cryder, PharmD, CACP,
implementation. BCACP
1:00PM - 3:00PM Type of Activity: Application- Alexandra Goncharenko,
RESIDENCY SHOWCASE based PharmD, BCPS
Oak & Brook Rooms 1.25 contact hours (0.125 CEUs) Brooke L. Griffin, PharmD,
UAN: 0121-0000-18-082-L01-P BCACP
No partial credit available. Mary Ann Kliethermes, BS,
Daniel Majerczyk, PharmD, PharmD, FAPhA
BCPS, BC-ADM, CACP Christie Schumacher, PharmD,
Kathleen Vest, PharmD, CDE, BCPS, BCACP, BC-ADM, CDE
BCACP Elizabeth Van Dril, PharmD,
Brooke L. Griffin, PharmD, BCPS
BCACP
28 2018 ICHP ANNUAL MEETINGWiFi
SATURDAY, SEPTEMBER 15 Network:
Events2018
Password:
Events2018
TRACK 2 – PHARMACY 9:30AM - 11:30AM
PRACTICE SESSION Crystal Room
8:00AM - 9:15AM DECONSTRUCTING
Crystal Room
QUALITY CONSTRUCTIVE FEEDBACK
IMPROVEMENT PEARLS At the end of this presentation,
• REDUCING HAZARDOUS DRUG pharmacist participants should be
EXPOSURE able to:
• UTILIZING EHR TOOLS 1. Differentiate between
TO IMPROVE IV TO PO feedback and evaluation.
CONVERSION 2. Identify factors that enhance
• IMAS: THE SOLUTION TO or diminish the impact of
PATIENT BARRIERS WITH HIGH feedback.
COST MEDICATIONS 3. Apply methods of effective
• UTILIZING LEAN SIX SIGMA feedback for learners,
METHODOLOGY TO PREVENT employees and/or peers.
MEDICATION OMISSIONS AT 4. Propose ways to seek and
DISCHARGE incorporate feedback for self-
At the end of this presentation,
development.
pharmacist participants should be
able to: At the end of this presentation,
1. Define Hazardous Drug and list technician participants should be
consequences of exposure. able to:
2. Describe strategies that can 1. Differentiate between
be implemented into the feedback and evaluation.
EHR to assist with IV to PO 2. Identify factors that enhance
conversion.
3. Describe the role and patient
or diminish the impact of
feedback.
POLLS:
PollEv.com/ichp OR
impact of an inpatient 3. Apply methods of effective
medication access specialist.
feedback for learners,
4. Identify decision making tools
available to evaluate possible
solutions within a quality
employees and/or peers.
4. Propose ways to seek and
PollEv.com/ichp3 OR
improvement project.
At the end of this presentation,
incorporate feedback for self-
development.
PollEv.com/ichp5
technician participants should be Type of Activity: Application- Varies by Room
able to:
1. Define Hazardous Drug and list
based
2.0 contact hours (0.2 CEUs)
Instructions on page 43
consequences of exposure. UANs: 0121-0000-18-085-L04-P
2. Describe strategies that can 0121-0000-18-085-L04-T
be implemented into the
No partial credit available.
EHR to assist with IV to PO
conversion. Jennifer Arnoldi, PharmD, BCPS
3. Describe the role and patient Jill Borchert, PharmD, BCPS,
impact of an inpatient FCCP
medication access specialist. Justin Schmidt, PharmD, BCPS,
4. Identify decision making tools BC-ADM
available to evaluate possible Tiffany Scott-Horton, PharmD,
solutions within a quality BCACP
improvement project.
Type of Activity: Knowledge-based
1.25 contact hours (0.125 CEUs)
UANs: 0121-0000-18-084-L05-P
0121-0000-18-084-L05-T
No partial credit available.
Stephanie Beam, PharmD, BCOP
Julie Downen, PharmD, BCPS,
CLSSBB
Jordan Johnson, PharmD
Ashlie Kallal, PharmD, CLSSBB
TRACK 3 – STUDENT SESSION
ELEVATE: TAKING PHARMACY TO NEW HEIGHTS 29SATURDAY, SEPTEMBER 15
8:00AM - 11:30AM 9:15AM - 9:30AM 4. Formulate effective strategies
Venetian Room Foyer to influence positive changes
in the opioid medication
THE ROAD TO RESIDENCY: BREAK
use process in a health care
PREPARATION PEARLS FOR organization.
PHARMACY STUDENTS Type of Activity: Application-
11:30AM - 1:00PM based
• General PGY-1 Info: What are
Terrace Room 2.0 contact hours (0.2 CEUs)
your options in ambulatory UANs: 0121-0000-18-086-L05-P
LUNCH & AWARDS PROGRAM
care and community 0121-0000-18-086-L05-T
• General PGY-1 Info: What No partial credit available.
are your options in hospital Adam Bursua, PharmD, BCPS
Annette Hays, PharmD, BCPS
and how to choose the right CLOSING GENERAL SESSION Laura Meyer-Junco, PharmD,
program for you 1:00PM - 3:00PM BCPS, CPE
• How to conduct yourself at Crystal Room Mary Lynn Moody, BSPharm
THE OPIOID CRISIS: EFFECTIVE Kevin O. Rynn, PharmD, FCCP,
the midyear/showcase and
DABAT
getting ready to be STRATEGIES TO TURN THE TIDE Christopher Schriever, MS,
interviewed At the end of this presentation, PharmD
• How to build your professional pharmacist participants should be
able to:
network 1. Develop an approach to 1:00PM - 3:00PM
• Financial planning for responsible opioid prescribing,
Oak & Brook Rooms
pharmacy students and reducing the risk of misuse,
abuse, and diversion of RESIDENCY SHOWCASE
residents
opioids.
• The match process/post- 2. Evaluate the role prescription
match scramble and Phorcas drug monitoring programs
• Get the inside scoop from a play in decreasing opioid
misuse and abuse.
residency preceptor 3. Order the effectiveness of
• Get the inside perspective various types of interventions
from residents: to ensure the safe use of opioid
Transitioning into the resident therapy.
4. Formulate effective strategies
role and work-life balance
Molly Rockstad, PharmD, BCPS
to influence positive changes
in the opioid medication
CPE DEADLINE
Susan Winkler, PharmD, BCPS, FCCP
Bonnie S. Bachenheimer, BS, PharmD
use process in a health care End of the day
MONDAY
organization.
Nora Flint, Pharm.D., FASHP, BCPS At the end of this presentation,
Christopher Crank, PharmD, MS,
BCPS-AQ ID
technician participants should be
able to: October 29, 2018
Jennifer Phillips, PharmD, BCPS 1. Develop an approach to
Brian Carlson, CFP, CLU responsible opioid prescribing,
Hailey P. Soni, PharmD, BCPS reducing the risk of misuse,
Milena McLaughlin, PharmD, MSC, abuse, and diversion of
BCPS-AQ ID, AAHIVP opioids.
Brittany Lee, PharmD 2. Evaluate the role prescription
Nathan Mitchell, PharmD drug monitoring programs
play in decreasing opioid
Student session is not accredited for CPE. misuse and abuse.
3. Order the effectiveness of
various types of interventions
to ensure the safe use of opioid
therapy.
30 2018 ICHP ANNUAL MEETINGYou can also read
